| Name |
Aspigola 8,75 mg po dozi, sprej za usnu sluznicu, otopina |
| Former Name |
Flurbiprofen Bayer 8,75 mg po dozi, sprej za usnu sluznicu, otopina |
| Marketing Authorisation Number |
HR-H-109653856 |
| Active Substance |
flurbiprofen |
| Composition |
jedna doza (3 potiska) sadržava 8,75 mg flurbiprofena jedan potisak sadržava 2,91 mg flurbiprofena jedan ml otopine u spreju za usnu sluznicu sadržava 17,16 mg flurbiprofena |
| Pharmaceutical Form |
Sprej za usnu sluznicu, otopina |
| Manufacturer |
Laboratorium Sanitatis S.L., Miñano, Alava, Španjolska |
| Marketing Authorisation Holder |
Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
| Marketing Authorisation Date |
24.11.2022 |
| MA Period of Validity |
24.11.2027 |
| Classification Number |
UP/I-530-09/21-01/129 |
| Registration Number |
381-12-01/70-22-09 |
| Prescription |
Medicinal product not subject to medical prescription |
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
allowed |
| ATC Code |
R02AX01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Summary of risk management plan |
download |
